Autoimmune encephalitis
Antibody-mediated encephalitis, its diagnosis and treatment.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 12, 16, 13, 17, 19.
All papers from the last 12 months
718 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Autonomic Dysfunction and Sleep Disorder in 35 Autoimmune EncephalitisSleep Med X2026 DecPMID 41907181
- Autoimmune encephalitis in older adults: Atypical presentation, therapeutic approaches and implication for diagnostic criteriaJ Neurol Sci2026 Nov 15PMID 42567003
- Neurocognitive sequelae following seronegative anti-NMDA receptor encephalitis with ovarian teratoma in a pediatric patient: A six-year follow-up case reportBrain Behav Immun Health2026 NovPMID 42825045
- Antibody-Dependent Cellular Phagocytosis and Cytotoxicity in Patients With LGI1 and CASPR2 EncephalitisNeurol Neuroimmunol Neuroinflamm2026 NovPMID 42777167
- Structural Brain Changes Are Linked to Clinical and Cognitive Outcomes in Anti-LGI1 EncephalitisNeurol Neuroimmunol Neuroinflamm2026 NovPMID 42753224
- Development and validation of the Pediatric Autoimmune encephalitis Severity Scale in children with autoimmune encephalitisDev Med Child Neurol2026 NovPMID 42691334
- Thalamic nuclei volumes and structural covariance network in patients with Anti-N-methyl-D-aspartate receptor encephalitisJ Clin Neurosci2026 NovPMID 42628386
- Long‑term seizure control with scheduled intravenous immunoglobulin in anti‑GAD antibody‑associated refractory temporal lobe epilepsy: a case reportSeizure2026 NovPMID 42623760
- Presenting and residual movement disorders in all-cause autoimmune encephalitisJ Neuroimmunol2026 NovPMID 42497469
- Clinical Reasoning: A 13-Year-Old Boy With Acute-Onset Generalized Dystonia, Rostrocaudal Gradient, and Severe Bulbar DysfunctionNeurology2026 Oct 27PMID 42821843
More neurology trends
All specialties →Anti-amyloid antibodies
Lecanemab, donanemab and related antibodies for early Alzheimer's disease.
New myasthenia gravis therapies
FcRn blockers and complement inhibitors in myasthenia gravis.
Key point: Terminal complement pathway inhibitors and neonatal Fc receptor antagonists are reshaping myasthenia gravis treatment, with robust evidence of efficacy and safety.
Wearable seizure detection
Wearable devices and algorithms to detect or forecast seizures.
Brain-computer interfaces
Devices that translate brain signals into control of computers or limbs.
Alpha-synuclein seed amplification
Seed amplification assays that detect misfolded alpha-synuclein.
BTK inhibitors in multiple sclerosis
Bruton's tyrosine kinase inhibitors studied in multiple sclerosis.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"autoimmune encephalitis"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.